Home›Compare›Pallas Health vs Raeliva

Pallas Health vs Raeliva: Which Is Better?

Head-to-head comparison of Pallas Health and Raeliva based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Pallas Health scores higher overall in our independent evaluation (65.7/100 vs 61.2/100), leading on trust & safety, product range, reputation. Raeliva comes out ahead on value, experience.

Pallas Health is a July 2026-launched telehealth platform offering compounded and branded GLP-1s, longevity peptides, women's HRT, ED and prescription skincare, with unusually detailed compliance disclosures.

Visit Pallas Health
61

Raeliva is a 2026-launched GLP-1 and longevity storefront built on the CareValidate platform, with flat dose-independent pricing and prepay discounts.

Visit Raeliva

Score Breakdown

DimensionPallas HealthRaeliva
Overall Score65.7/100 ✓61.2/100
Trust & Safety30%66/100 ✓60/100
Value25%70/10072/100 ✓
Experience20%58/10062/100 ✓
Product Range15%80/100 ✓55/100
Reputation10%48/100 ✓45/100

At a Glance

Founded20262026
HeadquartersNewark, DESan Diego, CA
Publicly tradedNoNo
Treatment categories62
Treatments listed127
Starting price$60/mo$117/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryPallas HealthRaeliva
Weight Loss / GLP-1$159–$239
Compounded Semaglutide (injectable)
$150–$219
Compounded Semaglutide Injections
Longevity & Peptides$139–$199
NAD+
$117–$179
NAD+

Pallas Health

+Detailed clinical-disclosure page names the operating entity, provider network (Lion MD), dispensing pharmacies and state-by-state visit rules
+Prices published for every product, including branded options (Wegovy pill, Foundayo, pens at cash rates)
+Broad catalog for a new entrant: compounded and branded GLP-1s, NAD+, sermorelin, glutathione, women's HRT, ED and prescription skincare
−Launched July 2026 with no public patient reviews, so service quality is unproven
−Billed every 4 weeks (13 charges a year); the $239 semaglutide renewal is well above the $139 first month
−A real-time video visit is required in 7 states plus DC, which adds friction for those patients
Read the full Pallas Health review →

Raeliva

+Clear operator disclosure: names the platform operator, the billing/intake vendor (CareValidate), the medical group (Lion MDs, with physician NPIs) and six dispensing pharmacies
+Flat pricing at every dose for semaglutide and tirzepatide, published on each product page
+Accepts transfers at the patient's current GLP-1 dose after provider review, with no charge if not eligible
−Launched in 2026 with ~1,500 claimed patients and only 12 Trustpilot reviews, all five-star and posted within two months
−Lowest advertised rates require 6- or 12-month prepayment ($900–1,450 upfront), and dispensed medication is non-refundable
−Runs on CareValidate's white-label telehealth stack, so the clinical and billing experience is shared with other storefronts
Read the full Raeliva review →

Pallas Health vs Raeliva — FAQ

Is Pallas Health better than Raeliva?

▾

Pallas Health scores higher overall in our independent evaluation (65.7/100 vs 61.2/100), leading on trust & safety, product range, reputation. Raeliva comes out ahead on value, experience.

Is Pallas Health or Raeliva cheaper?

▾

Pallas Health has the lower starting price (from $60/mo vs $117/mo for Raeliva). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Pallas Health and Raeliva both offer?

▾

Both platforms treat Weight Loss / GLP-1, Longevity & Peptides. Pallas Health covers 6 treatment categories total and Raeliva covers 2.

Still deciding?